by Catalin | Sep 7, 2026 | 2026 vol. 4 Issue 3
Nitric Oxide, Tumor Necrosis Factor-α, and Lipid Peroxidation as Biomarkers of Endothelial Injury in Sickle Cell Disease Fidelis Ohiremen OYAKHIRE, Grace Oluwapelumi BONIDEFAYE, Kikachukwu Favour OSAHOR, Juliana Edusola OLANIYAN, Tena Gloria LEMON, Jennifer...
by Catalin | Sep 7, 2026 | 2026 vol. 4 Issue 3
When the Eyes Speak: A Multisystem Challenge with CNS and Orbital Spread Light Chain Myeloma Nasim SALIMIAGHDAM, Usha NIRANJAN Introduction. Multiple myeloma (MM) is a type of cancer that affects plasma cells and makes up about 10% of blood cancer. It’s characterized...
by Catalin | Sep 7, 2026 | 2026 vol. 4 Issue 3
Unmasking VEXAS Syndrome: A Diagnostic Dilemma Kanupriya BECTOR, Ankur PUNIA, Shweta BANSAL, Sapna YADAV, Priyanka CHOUDHARY, Suchita VERMA, Omkar Kalidasrao CHOUDHARI, Ajay YADAV, Satyajeet SONI, Naveen GUPTA, Hemant MALHOTRA Background: VEXAS syndrome is caused by a...
by Catalin | Sep 7, 2026 | 2026 vol. 4 Issue 3
TP53-Mutated Myelodysplastic Syndrome with Bone Marrow Fibrosis in a Young Adult: A Rare Diagnostic and Therapeutic Challenge Mayank PANDEY, Tuphan Kanti DOLAI, Kaustav GHOSH Introduction: Myelodysplastic syndrome with fibrosis (MDS-F) is a rare and biologically...
by Catalin | Sep 7, 2026 | 2026 vol. 4 Issue 3
Kimura Disease – Not Every Lymphadenopathy is Malignant Vaishali SHARAI, Shweta BANSAL, Gaurav OJHA, Manish VIJAYVARGIYA, Vijeta NIRANJAN, Omkar Kalidasrao CHOUDHARI, Priyanka SONI, Naveen GUPTA, Hemant MALHOTRA Introduction. Any obvious lymphadenopathy should be...
by Catalin | Sep 7, 2026 | 2026 vol. 4 Issue 3
The Overture of DIC: An APL Case from Community to Cure Nasim SALIMIAGHDAM, Vivian Arguello GUERRA, Kristina ZARKUA Introduction: Acute promyelocytic leukemia (APL; M3) is a distinct subtype of acute myeloid leukemia characterized by fusion of the promyelocytic...
